CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. CBPO Income Statement

China biologic products holdings, inc. (CBPO)

Income statement / Quarterly

Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
External customers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41,137	41,664	34,395	35,847	40,580
Related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	166	0	75	156	327
Sales
89,277	91,453	77,634	86,525	91,421	85,587	68,284	78,750	79,068	70,354	57,987	68,923	60,073	56,266	42,592	53,152	53,580	54,031	33,995	53,124	50,466	47,227	35,652	41,303	41,665	34,470	36,003	40,908
External customers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,741	12,512	9,277	8,648	9,012
Related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	32	0	34	33	46
Cost of sales
30,110	32,215	30,861	27,647	31,482	34,043	27,021	27,944	27,054	24,461	21,033	22,356	18,919	17,715	15,579	17,165	16,122	16,616	10,068	16,921	16,130	15,715	10,418	13,774	12,512	9,311	8,682	9,058
Gross profit
59,167	59,237	46,773	58,878	59,939	51,544	41,262	50,805	52,013	45,892	36,953	46,567	41,154	38,551	27,013	35,986	37,458	37,414	23,927	36,202	34,335	31,511	25,233	27,529	29,152	25,159	27,321	31,849
Operating expenses
Selling expenses
3,577	3,807	4,407	3,017	3,026	1,227	2,743	2,674	2,604	1,950	2,674	2,420	3,329	2,282	3,813	2,551	2,441	1,836	1,884	3,545	4,165	4,826	5,404	3,703	3,038	2,449	2,229	1,856
General and administrative expenses
14,264	15,256	15,521	15,095	12,573	11,328	13,905	11,510	8,121	7,853	10,066	7,733	7,112	7,216	9,301	9,218	8,866	8,687	7,356	11,599	7,932	7,145	8,279	8,110	7,665	7,464	5,832	5,905
Research and development expenses
1,924	1,357	3,580	1,042	1,303	1,094	2,039	1,595	1,046	1,342	-538	1,788	1,838	1,073	1,421	1,053	835	913	755	637	929	710	1,539	509	1,218	710	431	1,317
Impairment loss of goodwill
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,064	-	-	0	-
Loss on abandonment and write-off of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,536	-	-	0	-
Income from operations
39,400	38,815	23,263	39,722	43,035	37,893	22,573	35,025	40,240	34,746	19,682	34,624	28,873	27,978	12,475	23,162	25,315	25,978	13,931	20,420	21,308	18,829	9,847	-9,394	17,230	14,534	18,827	22,769
Other income (expenses)
Equity in income/(loss) of an equity method investee
972	911	1,378	1,097	259	-216	-173	-376	-666	-95	6,870	-84	1,523	337	787	642	610	128	446	744	451	1,022	411	712	463	270	323	157
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	559	1,209	-3,086	2,863	11,175	1,021	3,792	2,270
Interest income
1,617	1,623	2,906	1,865	1,292	1,751	1,323	1,383	1,467	1,376	1,601	1,722	1,724	1,595	1,469	1,320	995	648	1,039	561	765	543	443	473	269	170	223	180
Interest expense
286	62	19	57	88	88	193	101	675	756	1,165	1,048	862	621	393	306	198	236	279	223	157	608	284	404	2,300	1,680	735	-619
Loss from disposal of a subsidiary
-	-	-	-75	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	223	449	-1	-100	-1,460	-63	846	224	142	102
Total other income, net
2,303	2,473	4,265	2,829	1,463	1,446	956	905	125	524	7,306	590	2,384	1,312	1,863	1,656	1,408	540	1,429	1,532	1,617	2,065	-1,835	3,581	8,762	-442	3,462	1,886
Income before income tax expense
41,703	41,289	27,528	42,552	44,498	39,340	23,530	35,930	40,365	35,271	26,989	35,214	31,257	29,290	14,339	24,819	26,723	26,519	15,361	21,952	22,926	20,894	8,012	-5,813	25,992	14,091	22,289	24,655
Income tax expense
6,867	6,950	4,348	7,163	7,006	6,607	3,200	6,052	6,123	5,616	9,807	7,007	4,486	5,338	2,316	4,871	3,745	4,606	5,173	3,479	3,333	3,176	296	1,022	5,317	4,263	3,373	4,961
Net income
34,836	34,338	23,180	35,388	37,491	32,733	20,329	29,878	34,242	29,655	17,181	28,206	26,771	23,952	12,023	19,947	22,977	21,912	10,188	18,473	19,592	17,718	7,715	-6,835	20,675	9,828	18,916	19,693
Less: Net income attributable to noncontrolling interest
3,806	4,346	3,742	6,997	6,738	6,535	4,049	7,001	7,518	6,492	4,323	8,146	7,046	5,678	3,195	5,251	6,815	6,996	4,379	4,855	6,753	4,760	3,081	2,525	4,075	3,519	5,182	6,757
Net income attributable to China Biologic Products Holdings, Inc.
31,030	29,991	19,437	28,391	30,753	26,197	16,279	22,876	26,723	23,162	12,858	20,060	19,724	18,273	8,827	14,696	16,161	14,915	5,808	13,617	12,838	12,957	4,634	-9,361	16,599	6,308	13,733	12,935
Earnings per share of ordinary share:
Basic
1.10	1.07	0.69	1.02	1.12	0.96	0.58	0.86	1.05	0.91	0.50	0.80	0.83	0.72	0.35	0.55	0.60	0.55	0.21	0.51	0.50	0.51	0.17	-0.37	0.67	0.26	0.58	0.55
Diluted
1.09	1.06	0.69	1.01	1.10	0.94	0.59	0.82	0.99	0.87	0.47	0.76	0.79	0.69	0.33	0.53	0.57	0.53	0.22	0.50	0.46	0.44	0.23	-0.37	0.28	0.23	0.39	0.41
Weighted average shares used in computation:
Basic
27,213	27,183	27,151	26,957	26,698	26,585	26,567	25,992	25,019	24,816	24,727	24,548	23,483	24,950	25,689	26,288	26,880	26,785	26,590	26,546	25,875	25,601	25,580	25,551	24,632	24,351	23,513	23,511
Diluted
27,478	27,465	27,420	27,297	27,152	27,126	26,825	27,056	26,320	26,066	26,101	25,787	24,719	26,132	26,856	27,449	28,067	27,915	27,164	27,018	26,627	26,547	28,648	25,551	26,738	25,680	26,578	26,599
Net income
34,836	34,338	23,180	35,388	37,491	32,733	20,329	29,878	34,242	29,655	17,181	28,206	26,771	23,952	12,023	19,947	22,977	21,912	10,188	18,473	19,592	17,718	7,715	-6,835	20,675	9,828	18,916	19,693
Other comprehensive income/(losses):
Foreign currency translation adjustment, net of nil income taxes
10,692	2,720	-17,062	-3,543	-13,267	2,569	-9,272	-15,704	1,463	-854	796	-125	527	-3,116	1,315	1,985	4,428	1,396	509	-86	136	1,176	955	2,064	2,699	1,126	-	-
Comprehensive income
45,528	37,059	6,118	31,844	24,224	35,302	11,056	14,173	35,705	28,800	17,977	28,081	27,298	20,835	13,338	21,933	27,406	23,308	10,697	18,386	19,728	18,895	8,671	-4,771	23,374	10,954	-	-
Less: Comprehensive income attributable to noncontrolling interest
4,859	4,650	1,213	6,365	4,468	6,978	2,396	4,015	7,831	6,455	4,471	8,081	7,140	5,105	3,481	5,586	7,723	7,159	4,470	4,926	6,750	5,015	3,349	3,656	4,526	3,787	-	-
Comprehensive income attributable to China Biologic Products Holdings, Inc.
40,668	32,408	4,904	25,479	19,755	28,324	8,660	10,157	27,874	22,345	13,506	19,999	20,158	15,730	9,856	16,346	19,682	16,149	6,226	13,460	12,977	13,879	5,322	-8,427	18,848	7,166	-	-